1. Home
  2. PRPO vs FTFT Comparison

PRPO vs FTFT Comparison

Compare PRPO & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPO
  • FTFT
  • Stock Information
  • Founded
  • PRPO N/A
  • FTFT N/A
  • Country
  • PRPO United States
  • FTFT United States
  • Employees
  • PRPO N/A
  • FTFT N/A
  • Industry
  • PRPO Biotechnology: Laboratory Analytical Instruments
  • FTFT Business Services
  • Sector
  • PRPO Industrials
  • FTFT Consumer Discretionary
  • Exchange
  • PRPO Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • PRPO 8.8M
  • FTFT 8.4M
  • IPO Year
  • PRPO N/A
  • FTFT N/A
  • Fundamental
  • Price
  • PRPO $4.44
  • FTFT $0.45
  • Analyst Decision
  • PRPO
  • FTFT
  • Analyst Count
  • PRPO 0
  • FTFT 0
  • Target Price
  • PRPO N/A
  • FTFT N/A
  • AVG Volume (30 Days)
  • PRPO 5.9K
  • FTFT 142.2K
  • Earning Date
  • PRPO 08-15-2024
  • FTFT 08-19-2024
  • Dividend Yield
  • PRPO N/A
  • FTFT N/A
  • EPS Growth
  • PRPO N/A
  • FTFT N/A
  • EPS
  • PRPO N/A
  • FTFT N/A
  • Revenue
  • PRPO $15,812,000.00
  • FTFT $36,594,555.00
  • Revenue This Year
  • PRPO $75.18
  • FTFT N/A
  • Revenue Next Year
  • PRPO N/A
  • FTFT N/A
  • P/E Ratio
  • PRPO N/A
  • FTFT N/A
  • Revenue Growth
  • PRPO 61.64
  • FTFT 53.89
  • 52 Week Low
  • PRPO $4.31
  • FTFT $0.40
  • 52 Week High
  • PRPO $8.99
  • FTFT $2.60
  • Technical
  • Relative Strength Index (RSI)
  • PRPO 29.52
  • FTFT 32.97
  • Support Level
  • PRPO $4.31
  • FTFT $0.40
  • Resistance Level
  • PRPO $5.12
  • FTFT $0.46
  • Average True Range (ATR)
  • PRPO 0.37
  • FTFT 0.06
  • MACD
  • PRPO -0.03
  • FTFT 0.01
  • Stochastic Oscillator
  • PRPO 10.74
  • FTFT 33.37

About PRPO Precipio Inc.

Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: